{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-003495","form_type":"8-K","ticker":"EDSA","cik":"0001540159","company_name":"Edesa Biotech, Inc.","filed_at":"2025-05-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.700965+00:00","generated_at":"2026-05-20T07:58:32.071993+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Edesa Biotech shareholders approve 1.725M share increase to 2019 equity plan","bullets":["Shareholders approved amendment to 2019 Equity Incentive Compensation Plan increasing share reserve by 1,725,000 shares.","Fungible share pool provisions removed; incentive stock option limit raised from 171,429 to 300,000 shares.","All seven director nominees elected: Chypyha, Liu, MacDonald, Marshall, Nijhawan, Olson, Sistilli.","Advisory vote on executive compensation approved with 2,215,325 for, 178,016 against.","MNP LLP appointed as independent auditor for fiscal year ending September 30, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-003495","json":"https://secwatch.observer/filing/0001171843-25-003495.json","markdown":"https://secwatch.observer/filing/0001171843-25-003495.md","text":"https://secwatch.observer/filing/0001171843-25-003495.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325003495/0001171843-25-003495-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325003495/f8k_052825.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T07:58:32.071993+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}